Psychiatric and Social Impacts of IVF

Sponsor
Assiut University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05881044
Collaborator
(none)
52
7

Study Details

Study Description

Brief Summary

To asses psychiatric impacts of In vitro fertilization.

Condition or Disease Intervention/Treatment Phase
  • Other: Psychiatric interview

Detailed Description

Infertility and its treatment represent a global health area of increasing importance. Individuals experiencing infertility represent around 8-10% of couples worldwide.

The demand for assisted reproduction techniques such as in-vitro fertilization (IVF) has increased in developed countries over the past decades, and is predicted to increase further in those to come .

This could be further boosted by numbers in resource-limited settings of the developing world, where an estimated 180 million couples are experiencing infertility.

The efficacy of IVF among the assisted fertility options has led an increasing number of individuals to seek this specific treatment. More than a half million babies are now born each year from IVF, as a result of over two million estimated annual treatment cycles . Yet it is also a relatively invasive and disruptive process that can be both physically and psychologically demanding .

Infertility itself has been associated with a higher prevalence of depression and anxiety, lower quality of life, and lower self-esteem .

The IVF process-which includes injectable medication and multiple blood tests, clinic appointments and procedures, waiting periods and anticipation of outcomes at each phase-may lead to further psychological stress. This can be exacerbated by disturbances to an individual's work and routine and the financial pressure of this costly treatment , and may be worse after multiple failed cycles .

Study Design

Study Type:
Observational
Anticipated Enrollment :
52 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Psychiatric and Social Impacts of In Vitro Fertilization.
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2023
Anticipated Study Completion Date :
Jan 1, 2024

Outcome Measures

Primary Outcome Measures

  1. Measurement of depression in couples with IVF . [Baseline]

    Measurement of psychiatric aspects in patients who perform or plan to perform in vitro fertilization by psychometric scales for measurement of depression such as The Hamilton Depression Rating Scale (HAM-D or HDRS) depression scale. Scores below 7 generally represent the absence or remission of depression. Scores between 7-17 represent mild depression Scores between 18-24 represent moderate depression Scores 25 and above represent severe depression

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Couples who perform or planning or failed to perform in vitro fertilization.

  • Age from 18y To 40y .

Exclusion Criteria:
  • Couples with any Psychiatric disorders prior to marriage.

  • Couples with any physical or mental handcapes.

  • refusal of couples to give consent to join the study.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Marina Hanna Abd elmalak bakhet, Principal Investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT05881044
Other Study ID Numbers:
  • Impacts of IVF
First Posted:
May 30, 2023
Last Update Posted:
May 31, 2023
Last Verified:
May 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of May 31, 2023